GE HealthCare Announces New Data Validating Artificial Intel

GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy1, based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer (SITC) in San Diego, U.S., by GE HealthCare, Vanderbilt University Medical ...

Related Keywords

San Diego , California , United States , Germany , Nashville , Tennessee , Vanderbilt University , Tennesseans , West German , Achim Struchholz , Mathilde Bouscaillou , John Howser , Jens Kleesiek , Travis Osterman , Julia Casey , Facebook , Ge Healthcare , Head Of The Medical Machine Learning Department , University Medicine Essen Media Contact , Linkedin , University Medicine Essen , Ge Healthcare Technologies Inc , Vanderbilt University Medical Center , Research Informatics , National Cancer Institute Imaging Steering Committee , Society For Immunotherapy Of Cancer , Twitter , Vanderbilt University Medical Center Media Contact , German Cancer Center Essen , German Cancer Center , Cancer Clinical Informatics At Vanderbilt Ingram Center , Patient Care Solutions , University Hospital Essen , Artificial Intelligence , Associate Vice President , Associate Chief Medical Information Officer , Cancer Clinical Informatics , Vanderbilt Ingram Cancer , Medical Machine Learning Department , Associate Director , West German Cancer Center , University Medicine , General Manager Molecular Imaging , Pharmaceutical Diagnostics , Molecular Imaging , Care Technologies , University Medical Center , Medical Center , Middle Tennesseans , West German Cancer Center Essen , Newsweek World , Best Smart Hospitals , Machine Learning Models , Predict Efficacy , Immune Checkpoint Inhibitors Using , External Real World Pan Cancer , Care Media Contact , University Medical Center Media Contact , Medicine Essen Media Contact ,